share_log

鲁抗医药(600789.SH):公司及控股子公司参与全国药品集中采购拟中标

Shandong Lukang Pharmaceutical (600789.SH): The company and its holding subsidiaries participate in the national pharmaceutical centralized procurement and are expected to win the bid.

Gelonghui Finance ·  Dec 19 16:08

On December 19, Gelonghui reported that Shandong Lukang Pharmaceutical (600789.SH) announced that the company and its controlling subsidiary, ShanDong Lukang Pharmaceutical Group Saiter Co., Ltd. (referred to as "Saiter Company"), participated in the bidding for the tenth nationwide centralized Pharmaceutical procurement organized by the Joint Procurement Office. The company and Saiter Company intend to have some of their Pharmaceuticals selected in this centralized procurement.

big
big
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment